MARKETS / BALCAO / AOXY
BALCAO · REAL ESTATE · SMALL CAP

Advanced Oxygen Technologies, Inc. AOXY

17 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$43,445
▲ 2.0% vs FY2023
EPS · FY24
$0.00
Dividend / sh · FY24
Payout · FY24
ROE · FY24
1.1%
Net margin · FY24
9.5%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 43,445.00
Revenue, FY2024 · full 17-year series below
Revenue Net income
2.5e-055e-057.5e-050.00010.00.02008201120142017202020232024
2.5e-055e-057.5e-050.00010.00.02015201820212024

10 cents of every revenue dollar became profit this year.

Per share
USD 0.00
Diluted EPS, FY2024
EPS
0.40.81.20.002008201120142017202020232024
0.40.81.20.002015201820212024

The company pays no cash dividend.

Profitability
1.1%
Return on equity, FY2024
ROE
81624321.1%2008201120142017202020232024
81624321.1%2015201820212024
Operating margin31.7%
Net margin9.5%
Return on assets0.6%

Each USD of equity produced 1 cents of profit this year.

Returned to shareholders
returned in FY2024 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+0.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+3.2%
+0.1%
+1.2%
−0.5%
Net income
−58.3%
−13.8%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.00B
Shares outstanding, FY2024
0.050.002008201120142017202020232024
0.000.002015201820212024
Change, 5 years+0.0%
Change, 10 years+43.6%

The share count grew 0% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 693,077.00
total assets, end of FY2024
Total assetsUSD 693,077.00
EquityUSD 415,614.00
CashUSD 57,225.00
Gross debtUSD 127,029.00
Net debtUSD 69,804.00
Current ratio0.39×

Net debt stands at 17% of equity.

History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
0.0
·
0.0
−0.0
0.0
·
·
·
·
·
0.0
0.0
−0.0
0.0
0.0
EBITDA $B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
·
·
·
·
·
Net income $B
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
−0.0
0.0
EPS, diluted $
0.00
0.00
0.00
0.02
0.00
−0.03
0.00
0.00
0.00
0.00
−0.01
−0.00
0.00
−0.00
0.00
0.00
0.00
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
1.1
1.6
0.7
17.1
1.8
−34.0
2.7
2.5
0.0
4.2
7.0
−24.3
13.2
−7.9
30.8
−43.8
24.3
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.05
0.05
0.05
0.05
0.05
0.05
0.05

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
42 of 42
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed